by PRISMS | Sep 23, 2023 | Research Study
The purpose of this study is to develop and validate a disease-specific, observer-reported outcome measure for clinical trials of patients with the following Neurodevelopmental Disorders (NDDs): SYNGAP1 and RAI1 deficiencies (such as SMS), and Fragile X Syndrome. The...
by PRISMS | Aug 29, 2023 | 30th Anniversary, Awareness, SMS Blog, Uncategorized
A Q&A with PRISMS Community Fundraisers By: Jackie Fallenstein – PRISMS Board Member-at-Large One of the ways PRISMS members and friends support our mission is by holding fundraisers in their local communities. In 2022, these fundraisers raised over $60,000 for...
by PRISMS | Aug 10, 2023 | 30th Anniversary, From PRISMS, Home Page
Rare diseases like Smith-Magenis syndrome may affect a small number of individuals, but their impact can be devastating. These conditions are characterized by their scarcity, which poses unique challenges for research, diagnosis, and treatment. However, one of the...
by PRISMS | Jul 26, 2023 | Awareness, Home Page, SMS Blog
Can you tell us a little bit about yourself, your family, and your SMS individual? I am North Carolina born and raised, transplanted to Arizona since 1996. I earned a Bachelor of Science degree in elementary education from Appalachian State University and then a...
by PRISMS | Jul 24, 2023 | 30th Anniversary, From PRISMS, Home Page
PRISMS is proud to announce a new addition to the Board of Directors, Eric Rogers. Eric will serve as a Member-At-Large. Eric and his wife Jessica live in Mount Juliet, TN with their son Wyatt (9) who has SMS, and daughter Adelyn (5). Eric attended Cumberland...
